Pfizer-BioNTech Covid-19 vaccine receives UK approval for children

Pfizer-BioNTech Covid-19 vaccine receives UK approval for children

Source: 
Pharmaceutical Business Review
snippet: 

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has expanded the emergency use authorisation (EUA) for Pfizer and BioNTech’s Covid-19 mRNA vaccine called BNT162b2 to include use in children aged 12 to 15 years.